Cellid Co., Ltd.
Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.
299660 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울시 관악구 관악로 1 서울대학교 142동 5층, 서울시
- Website:
- http://www.cellid.co.kr
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Cellid Co., Ltd. is a research and development-focused biotechnology company specializing in immunotherapeutic vaccines for cancer and infectious diseases. The company's core business is centered on its proprietary technology platforms. Its key offering, CeliVax, is an anti-cancer immunotherapeutic vaccine platform that utilizes a patient's own B cells and monocytes, designed to be applicable to any cancer with identified antigens. In addition, Cellid has developed an adenovirus vector-based platform for creating preventive vaccines against infectious diseases, notably used in the development of a COVID-19 vaccine. The company's pipeline is focused on leveraging these technologies to address significant unmet medical needs in oncology and virology.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Cellid Co., Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all Cellid Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Cellid Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
